| 引用本文: | 李堂雪,李会婷,吴妍,汪电雷,史天陆.HLA-B基因多态性与抗癫痫药拉莫三嗪致皮肤不良反应关系的meta分析[J].中国现代应用药学,2024,41(1):126-132. |
| LI Tangxue,LI Huiting,WU Yan,WANG Dianlei,SHI Tianlu.Meta-analysis of Association Between HLA-B Gene Polymorphism and Antiepileptic Lamotrigine-induced Cutaneous Adverse Drug Reactions[J].Chin J Mod Appl Pharm(中国现代应用药学),2024,41(1):126-132. |
|
| 摘要: |
| 目的 系统评价人类白细胞抗原B(human leukocyte antigen B，HLA-B)基因多态性与抗癫痫药拉莫三嗪致皮肤不良反应(lamotrigine-cutaneous adverse reactions，LTG-cADRs)的相关性。方法 通过计算机全面检索中国期刊全文数据库、万方数字化期刊全文库、中国科技期刊全文数据库、PubMed、Web of Science、Science Direct数据库，检索时间截至2022年7月15日，采用RevMan5.4软件进行meta分析。结果 共纳入16篇病例对照研究，331例LTG-cADRs癫痫患者，其中94例拉莫三嗪致史-约综合征/中毒性表皮坏死松懈症(lamotrigine-Stevens-Johnson syndrome/toxic epidermal necrolysis，LTG-SJS/TEN)患者，232例拉莫三嗪致斑丘疹(lamotrigine-maculopapule，LTG-MPE)患者，5例伴嗜酸粒细胞增多和系统症状的药疹(lamotrigine-drug rash with eosinophilia and systemic symptoms，LTG-DRESS)患者；612例拉莫三嗪耐受癫痫患者。Meta分析结果显示：HLA-B*1502等位基因与LTG-SJS/TEN存在显著相关性(OR=3.03，95%CI：1.70~5.39，P=0.000 2)。HLA-B*1502、HLA-B*5801、HLA-B*1302等位基因均与LTG-MPE无显著相关性。结论 HLA-B*1502等位基因与LTG-SJS/TEN存在相关性，可能是LTG-SJS/TEN风险基因；HLA-B*1502、HLA-B*5801和HLA-B*1302等位基因与LTG-MPE无相关性。 |
| 关键词: HLA-B 拉莫三嗪 皮肤不良反应 癫痫 meta分析 |
| DOI：10.13748/j.cnki.issn1007-7693.20223831 |
| 分类号:R969.3 |
| 基金项目:安徽省质量基础设施标准化专项(2022MKS06)；安徽省高校自然科学研究项目(2023AH040397) |
|
| Meta-analysis of Association Between HLA-B Gene Polymorphism and Antiepileptic Lamotrigine-induced Cutaneous Adverse Drug Reactions |
|
LI Tangxue1, LI Huiting2, WU Yan2, WANG Dianlei1, SHI Tianlu1,2
|
|
1.School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China;2.Department of Pharmacy, the First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital, Hefei 230001, China
|
| Abstract: |
| OBJECTIVE To systematically evaluate the association between human leukocyte antigen B(HLA-B) gene polymorphisms and lamotrigine-induced cutaneous adverse drug reactions(LTG-cADRs). METHODS CNKI, Wanfang Data, VIP, PubMed, Web of Science, Science Direct were comprehensively searched from the inception to July 15, 2022. The software RevMan 5.4 was used for the meta-analysis. RESULTS A total of 16 case-control studies were included, 331 patients with LTG-cADRs epilepsy, including 94 lamotrigine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis(LTG-SJS/TEN) patients, 232 lamotrigine-maculopapule(LTG-MPE) patients and 5 lamotrigine- drug rash with eosinophilia and systemic symptoms(LTG-DRESS) patients; 612 lamotrigine-tolerant patients. Meta-analysis results showed that the HLA-B*1502 allele was significantly associated with LTG-SJS/TEN(OR=3.03, 95%CI: 1.70−5.39, P=0.000 2). The HLA-B*1502, HLA-B*5801, HLA-B*1302 alleles were not significantly associated with LTG-MPE. CONCLUSION HLA-B*1502 allele is associated with LTG-SJS/TEN, which may be a risk gene for LTG-SJS/TEN. HLA-B*1502, HLA-B*5801, HLA-B*1302 are not associated with LTG-MPE. |
| Key words: HLA-B lamotrigine cutaneous adverse drug reactions epilepsy meta-analysis |
